Quant Biomarkers

General Information

Company Name

Quant Biomarkers

Founded Year

2021

Location (Offices)

Basel, Switzerland +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Marketing

Funding Stage

Social Media

Quant Biomarkers - Company Profile

Quant Biomarkers is a data-driven biomedical and Longevitytech company focused on the analysis and validation of longitudinal clinical data and personalized biomarker assessment to support intervention decisions and Longevity Medicine therapeutic modalities. The company, founded in 2021, operates within the biotechnology and marketing industries. Quant Biomarkers aims to drive effective clinical care by leveraging rapidly advanced biological science and technology for informed clinical decisions. As of now, there is no public information available regarding the headquarters, last investment, or investors of the company.

Taxonomy: Biomedical Data Analysis, Longevity Technology, Personalized Biomarkers Assessment, Longevity Medicine, AI and Tech-Powered Platforms, Biomarkers of Human Longevity, Oncology Biomarker Development, Investment De-risking, R&D Acceleration, IP Acquisition, Precision Health Products, Longevity Preventive Medicine, Financial and Analytical Services